Estimation of the financial burden to the national health insurance for patients with major cancers in Taiwan

Journal of the Formosan Medical Association

Volumn 107, Issue 1, 2008, Pages 54-63

  Chu, Po Ching ^a   Hwang, Jing Shiang ^b   Wang, Jung Der ^a,c   Chang, Yu Yin ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cancer; Health expenditure; Health insurance; Monte Carlo method

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DATA BASE; FEASIBILITY STUDY; FINANCIAL MANAGEMENT; FOLLOW UP; HEALTH CARE PLANNING; HUMAN; LEUKEMIA; LIFE EXPECTANCY; LIFESPAN; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MEDICAL CARE; MONTE CARLO METHOD; MORBIDITY; NATIONAL HEALTH INSURANCE; NEOPLASM; PREVENTIVE HEALTH SERVICE; PROBABILITY; REIMBURSEMENT; SOCIOECONOMICS; SURVIVAL TIME; TAIWAN;

EID: 39549092817     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(08)60008-X     Document Type: Article

References (27)

1. Office for National Statistics, UK. Cancer Statistics Registrations Series MB1 No. 34. London: Office for National Statistics, UK, 2005.
2. Bureau of National Health Insurance, Taiwan, R.O.C. 2003 National Health Insurance Annual Statistics Report. Taipei: Bureau of National Health Insurance, Taiwan, R.O.C., 2004. [In Chinese]
3. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 2001;22:91-113.
4. Lee JM, Turini M, Botteman MF, et al. Economic burden of head and neck cancer. A literature review. Eur J Health Econ 2004;5:70-80.
5. Avritscher EB, Cooksley CD, Grossman HB, et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 2006;68:549-53.
6. Kutikova L, Bowman L, Chang S, et al. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer 2005;50:143-54.
7. Mullins CD, Wang J, Cooke JL, et al. Longitudinal versus cross-sectional methodology for estimating the economic burden of breast cancer: a pilot study. Pharmacoeconomics 2004;22:285-91.
8. Maroun J, Ng E, Berthelot JM, et al. Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can 2003;24:91-101.
9. Hwang JS, Wang JD. Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Stat Med 1999;18:1627-40.
10. Ho JJ, Hwang JS, Wang JD. Life-expectancy estimations and the determinants of survival after 15 years of follow-up for 81,249 workers with permanent occupational disabilities. Scand J Work Environ Health 2006;32:91-9.
11. Ho WL, Lin KH, Wang JD, et al. Financial burden of national health insurance for treating patients with transfusion-dependent thalassemia in Taiwan. Bone Marrow Transplant 2006;37:569-74.
12. Fang CT, Chang YY, Hsu HM, et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy QJM-INT J MED 2007; 100:97-105.
13. Lu JF, Hsiao WC. Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood) 2003;22:77-88.
14. MC-QAS software for estimating expected quality-adjusted survival time. Available from http://www.stat.sinica.edu.tw/jshwang/qas.htm [Date accessed: January 2, 2006]
15. Lipscomb J, Weinstein MC, Torrance GW. Time preference. In: Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996:214-46.
16. National Treasury Agency, Ministry of Finance, Taiwan. Business Annals of National Treasury Agency: Issuance Information of Central Government Bonds. 2003;Jun: 90-2.
17. Directorate-General of Budget, Accounting and Statistics Executive Yuan, Taiwan. Commodity-Price Statistics Monthly in Taiwan: Consumer Price Indices by Basic Group in Taiwan Area. 2004;Oct:21.
18. Ho JJ, Hwang JS, Wang JD. Estimation of reduced life expectancy from serious occupational injuries in Taiwan. Accid Anal Prev 2006;38:961-8.
19. Hsu C, Wang JD, Hwang JS. Survival-weighted health profile for long-term survivors of acute myelogenous leukaemia. Qual Life Res 2003;12:503-17.
20. Chen THH, Chiu YC, Luh DL, et al. Taiwan Community-based Integrated Screening Group. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 2004;100:1734-43.
21. Pasini G, Polselli A, Tonelli U, et al. Evaluation of the cost of home care for terminally ill cancer patients. Support Care Cancer 1997;5:396-401.
22. Fireman BH, Quesenberry CP, Somkin CP, et al. Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 1997;18:51-76.
23. Wang JD. Study design. In: Wang JD. Basic Principles and Practical Applications in Epidemiological Research. Singapore: World Scientific, 2002:161-96.
24. Kenkal D. Cost of illness approach. In: Tolley G, Kenkal D, Fabian R. Valuing Health for Policy: An Economic Approach. Chicago: The University of Chicago Press, 1994: 42-71.
25. Cunningham K. Cost of illness handbook. U.S. EPA. Available from http://www.epa.gov/oppt/coi/ [Date accessed: November 9, 2005]
26. Garber AM, Weinstein MC, Torrance GW, et al. Theoretical foundations of cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996:25-53.
27. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financ Rev 1985;7:61-80.